A randomized multicenter open-label controlled trial to show that mucous fistula refeeding reduces the time from enterostomy closure to full enteral feeds (MUCous FIstula REfeeding ("MUC-FIRE") trial)

一项随机多中心开放标签对照试验表明,粘液瘘再喂养可缩短从肠造口闭合到完全肠内喂养的时间(MUCous FIstula REfeeding(“MUC-FIRE”)试验)

基本信息

项目摘要

Enterostomies in children may be created for different reasons. During the presence of an enterostomy the regular stool transfer is interrupted as the distal part of the bowel (the part following the enterostomy) does not participate in the circulation of stool. Therefore it does not contribute to the resorption of enteral contents. As a consequence these children need additional partenteral nutrition. Due to the negative side-effects of parenteral nutrition all patients should return to enteral nutrition as soon as possible. Consequently, many pediatric surgical centers worldwide routinely perform mucous fistula refeeding (MFR) into the former unused bowel after enterostomy creation because case reports and retrospective analyses show low complication rates and faster postoperative weight gain. Several providers, however, shy away from this approach because to date there is still no high quality evidence for the benefit of this treatment. Case reports and retrospective analyses show low complication rates and faster postoperative weight gain. The aim of this study is to assess the effects of mucous fistula refeeding in a randomized, prospective trial. We hypothesize that MFR between enterostomy creation and enterostomy closure reduces the time to full enteral feeds after enterostomy closure compared to standard of care. Moreover, the side effects of parenteral nutrition may be reduced and the postoperative hospital care of infants undergoing ostomy closure shortened.
儿童肠造口可能出于不同的原因。在进行肠造口术期间,由于肠的远端部分(肠造口术之后的部分)不参与粪便循环,因此常规粪便转移被中断。因此,它不会促进肠内容物的吸收。因此,这些儿童需要额外的肠外营养。由于肠外营养的副作用,所有患者都应尽快恢复肠内营养。因此,世界各地的许多儿科外科中心在肠造口术后常规对以前未使用的肠道进行粘液瘘再喂养(MFR),因为病例报告和回顾性分析显示并发症发生率低且术后体重增加更快。然而,一些提供者回避这种方法,因为迄今为止仍然没有高质量的证据证明这种治疗的益处。病例报告和回顾性分析显示并发症发生率低,术后体重增加更快。本研究的目的是在一项随机、前瞻性试验中评估粘液瘘再喂养的效果。我们假设,与标准护理相比,肠造口术创建和肠造口术闭合之间的 MFR 减少了肠造口术闭合后完全肠内喂养的时间。此外,可以减少肠外营养的副作用,并缩短接受造口闭合的婴儿的术后住院护理时间。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Professor Dr. Martin Lacher其他文献

Professor Dr. Martin Lacher的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Professor Dr. Martin Lacher', 18)}}的其他基金

Rolle des Kindlin-1 (KIND1) Gens bei nekrotisierender Enterocolitis (NEC) und chronisch entzündlichen Darmerkrankungen (CED) im Kindesalter
kindlin-1 (KIND1) 基因在儿童坏死性小肠结肠炎 (NEC) 和炎症性肠病 (IBD) 中的作用
  • 批准号:
    190794232
  • 财政年份:
    2010
  • 资助金额:
    --
  • 项目类别:
    Research Grants

相似海外基金

Arthroscopic-assisted tibial plateau fixation (AATPF) vs. Open reduction internal fixation (ORIF): A multicenter randomized controlled trial
关节镜辅助胫骨平台固定术 (AATPF) 与切开复位内固定术 (ORIF):一项多中心随机对照试验
  • 批准号:
    10723527
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
A Phase 2, randomized, double-blind, 4-arm, multicenter study to demonstrate the efficacy and safety of topical dosage formulations of a prescription drug product for actinic keratosis
一项 2 期、随机、双盲、4 组、多中心研究,旨在证明处方药局部剂量制剂治疗光化性角化病的有效性和安全性
  • 批准号:
    10820810
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Mechanisms of Open and Hidden Placebo in Stroke Recovery
开放式和隐藏式安慰剂在中风康复中的机制
  • 批准号:
    10642441
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Intermediate-sized Expanded Access Protocol for CNM-Au8 in Amyotrophic Lateral Sclerosis (ALS).
CNM-Au8 在肌萎缩侧索硬化症 (ALS) 中的中等规模扩展访问协议。
  • 批准号:
    10835565
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Chronic Subdural Hematoma Treatment with Embolization vs Surgery or MedicalManagement Study (CHESS)
慢性硬膜下血肿栓塞治疗与手术或医疗管理研究 (CHESS)
  • 批准号:
    10733715
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Translamina Cribrosa Pressure Gradient Model of Normal Tension Glaucoma
正常眼压青光眼的筛板压力梯度模型
  • 批准号:
    10527362
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Personalizing Therapies for Acute Kidney Injury in Cirrhosis
肝硬化急性肾损伤的个体化治疗
  • 批准号:
    10663170
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
A Clinical Trial of GenomeDiver for Improved Diagnosis of Pediatric Rare Diseases
GenomeDiver 改善儿科罕见病诊断的临床试验
  • 批准号:
    10689316
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
A Clinical Trial of GenomeDiver for Improved Diagnosis of Pediatric Rare Diseases
GenomeDiver 改善儿科罕见病诊断的临床试验
  • 批准号:
    10433004
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Personalizing Therapies for Acute Kidney Injury in Cirrhosis
肝硬化急性肾损伤的个体化治疗
  • 批准号:
    10371378
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了